KR840003254A - Method for preparing 6-substituted-s-triazolo [3,4-a] phthalazine derivatives - Google Patents

Method for preparing 6-substituted-s-triazolo [3,4-a] phthalazine derivatives Download PDF

Info

Publication number
KR840003254A
KR840003254A KR1019830000174A KR830000174A KR840003254A KR 840003254 A KR840003254 A KR 840003254A KR 1019830000174 A KR1019830000174 A KR 1019830000174A KR 830000174 A KR830000174 A KR 830000174A KR 840003254 A KR840003254 A KR 840003254A
Authority
KR
South Korea
Prior art keywords
group
substituted
general formula
formula
alkyl
Prior art date
Application number
KR1019830000174A
Other languages
Korean (ko)
Other versions
KR890000184B1 (en
Inventor
옥셀리 에밀리오 (외 3)
Original Assignee
레나토 스가트비
그루포 레페티트 에스. 피. 에이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 레나토 스가트비, 그루포 레페티트 에스. 피. 에이 filed Critical 레나토 스가트비
Publication of KR840003254A publication Critical patent/KR840003254A/en
Application granted granted Critical
Publication of KR890000184B1 publication Critical patent/KR890000184B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/34Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals

Abstract

내용 없음No content

Description

6-치환-s-트리아졸로〔3,4-a〕프탈라진 유도체의 제조방법Method for preparing 6-substituted-s-triazolo [3,4-a] phthalazine derivatives

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.

Claims (8)

하기 일반식(Ⅱ)의 4-치환-1-히드라지노-프탈라진을 적당한 환화제(環化劑)로써 환화시키고 통상의 방법에 의하여 트리아졸로〔3,4-a〕프탈라진 핵의 3-위치에 있는 치환체를 임의적으로 변환시킴을 특징으로 하는 하기 일반식(Ⅰ)로 표시되는 s-트라아졸로〔3,4-a〕프탈라진의 제조방법.4-substituted-1-hydrazino-phthalazine of the following general formula (II) was cyclized with a suitable cyclizing agent, and triazolo [3,4-a] phthalazine nucleus was prepared by a conventional method. A process for producing s-triazolo [3,4-a] phthalazine represented by the following general formula (I), characterized by optionally converting a substituent in the 3-position. 상기 일반식에서,In the above formula, R는 수소원소, 수산기, (C1-C6)알킬기, 페닐기, 또는 (C1-C6)알킬기, (C1-C6)알콕시기, 클로로, 플루오로, 요오드, 페닐기,수산기,아미노기, 모노-및 디-(C1-C4)알킬아미노기,(C1-C4) 알칸오일 아미노기, 피페리디노기, 시아노기, 니트로기, 트리플루오로메틸기, 카르복시기 및 카르바밀기에서 선택된 1-3개의 치환체로 치환된 페닐기를 나타내거나, 또는 R는 카르보-(C1-C4)알콕시기 클로로메르캅토기, (C1-C4)알킬티오기, (C1-C4)알킬술피닐기, (C1-C4)알킬술포닐기, 일반식 |의 아미노 또는 치환아미노기이며, 이 식에서 R4및 R5는 각각 수소원자, (C1-C4)알킬기, (C1-C4)알켄일기 또는 수산기, (C1-C4)알콕시기, 할로겐원자, 카르복시기, 시아노기, 아미노카르보닐기, 모노-또는 디-(C1-C4)알킬아미노카르보닐기, (C1-C4)알콕시카르보닐기, (C1-C4) 알콕시티오카르보닐기 및 (C1-C4)알킬티카르보닐기에서 선택된 1개 또는 2개의 기로써 치환된(C1-C4)알킬기를 나타내거나, 또는 R4및 R5는 페닐기 부분은 물론 알킬기 부분이 위에서 정의한 것과 같이 치환될 수 있는 페닐-(C1-C4) 알킬기 또는 치환페닐-(C1-C4)알킬기이며, 또한 인접한 질소원자와 하나로 뭉친 R4및 R5는 질소원자, 산소원자 및 황에서 선택된 헤테로원자를 함유하고 임의적으로 (C1-C4)알킬기, 페닐기, 위와 같이 치환된 페닐기, 수산기 및 카르보-(C1-C4)알콕시기에 선택된 1개 또는 2개의 치환체를 함유할 수 있는 포화 4,5,6 또는 7-원환 헤테로 고리를 나타낼 수 있으며, 또한 R는 일반식 -OR6의 알콕시기 또는 시클로알콕시기를 나타내는데, 여기서 R6는 수산기, 아미노기, 모노-디-(C1-C4)알킬아미노기, (C1-C4)알콕시기, 할로겐원자, 옥소, 카르복시, 아미노카르보닐기, 모노-또는 디-(C1-C4)알킬아미노카르보닐기, (C1-C4)알콕시카르보닐기, (C1-C4)알콕시티오카르보닐기 및 (C1-C4)알킬티오카르보닐기 중에서 선택된 1개 또는 2개의 기로 치환된 (C1-C4)알킬기를 나타내며, 또한 R6는 질소, 산소 및 황에서 선택된 헤테로 원자를 함유할 수 있고 임의적으로 (C1-C4)알킬기, 페닐기, 치환페닐기, 수산기 및 카르보-(C1-C4)알콕시기에서 선택된 1개 또는 2개의 치환체를 함유할 수도 있는 포화 4,5,6 또는 7-원환 헤테로고리이거나, 또는 R6는 1개 또는 그 이상의 수산기 및 (C1-C4)알콕시기로써 임의적으로 치환된 (C1-C4)시클로알킬기이며,R is a hydrogen element, hydroxyl group, (C 1 -C 6 ) alkyl group, phenyl group, or (C 1 -C 6 ) alkyl group, (C 1 -C 6 ) alkoxy group, chloro, fluoro, iodine, phenyl group, hydroxyl group, amino group 1 selected from mono- and di- (C 1 -C 4 ) alkylamino groups, (C 1 -C 4 ) alkanoyl amino groups, piperidino groups, cyano groups, nitro groups, trifluoromethyl groups, carboxyl groups and carbamyl groups Or a phenyl group substituted with -3 substituents, or R represents a carbo- (C 1 -C 4 ) alkoxy group, a chloromercapto group, a (C 1 -C 4 ) alkylthio group, (C 1 -C 4 ) Alkylsulfinyl group, (C 1 -C 4 ) alkylsulfonyl group, general formula | Is an amino or substituted amino group of wherein R 4 and R 5 are each a hydrogen atom, (C 1 -C 4 ) alkyl group, (C 1 -C 4 ) alkenyl group or hydroxyl group, (C 1 -C 4 ) alkoxy group, Halogen atom, carboxyl group, cyano group, aminocarbonyl group, mono- or di- (C 1 -C 4 ) alkylaminocarbonyl group, (C 1 -C 4 ) alkoxycarbonyl group, (C 1 -C 4 ) alkoxythiocarbonyl group and (C 1 -C 4) substituted by one or two groups selected from alkylthio groups (C 1 -C 4) represent an alkyl group, or R 4 and R 5 is a substituted phenyl group, as well as part of the alkyl moiety as defined above, A phenyl- (C 1 -C 4 ) alkyl group or a substituted phenyl- (C 1 -C 4 ) alkyl group, and R 4 and R 5, which are combined together with adjacent nitrogen atoms, are heteroatoms selected from nitrogen atoms, oxygen atoms and sulfur. Atom containing and optionally (C 1 -C 4 ) alkyl group, phenyl group, phenyl group substituted as above, hydroxyl group and carbo- (C 1 -C 4 ) alkoxy group may represent a saturated 4,5,6 or 7-membered cyclic hetero ring which may contain one or two substituents selected, wherein R is an alkoxy group or cycloalkoxy of the formula -OR 6 Wherein R 6 represents a hydroxyl group, an amino group, a mono-di- (C 1 -C 4 ) alkylamino group, a (C 1 -C 4 ) alkoxy group, a halogen atom, oxo, carboxy, aminocarbonyl group, mono- or di- (C 1 -C 4) alkylamino group, (C 1 -C 4) alkoxycarbonyl, (C 1 -C 4) alkoxy group and a thio (C1-C4) alkylthio group selected from a one or two groups substituted (C 1 -C 4 ) alkyl group, R 6 may also contain a hetero atom selected from nitrogen, oxygen and sulfur and optionally (C 1 -C 4 ) alkyl group, phenyl group, substituted phenyl group, hydroxyl group and carbo- (C 1 -C 4) may contain one or two substituents selected from an alkoxy group with a saturated 4, 5, 6 or Or a 7-membered ring heterocycle, or R 6 is a (C 1 -C 4 ) cycloalkyl group optionally substituted with one or more hydroxyl groups and (C 1 -C 4 ) alkoxy group, R1은 할로겐원자, 수산기, (C1-C4)알킬티오기, (C1-C4)알킬술피닐기, (C1-C4)알킬술포닐기, 페닐기, 위에서와 같이 치환된 페닐기, 일반식의 아미노 또는 치한아미노기에서 선택된 것이며, 여기서 R7및 R8는 위의 R4및 R5에서 정의한 것과 일반식 -OR9의 알콕시기 또는 시클로알콕시기 이고, R2및 R3는 각각 수소원자, 할로겐원자, (C1-C4)알킬기, (C1-C4)알콕시기 및 니트로기를 나타내는데 이것은 R2 및 R3가 똑같이 수소원자이고, R1이 클로로원자일 때 R는 페닐기 또는 4-니트로페닐기가 될 수 없으며, R1이 수산기일때는 R은 페닐기가 될 수 없고, R 및 R1이 각각 -O-R6또는 -OR9인 조건을 갖출 때이며, 여기서 R6및 R9은 위에서 정의한 포화헤테로 고리이고, 이 헤테로 고리중의 헤테로 원자는 직접 산소원자와 결합할 수 없다.R 1 is a halogen atom, a hydroxyl group, (C 1 -C 4) alkylthio, (C 1 -C 4) alkylsulfinyl group, (C 1 -C 4) alkylsulfonyl group, a phenyl group, a phenyl group substituted as above, General formula R 7 and R 8 are an alkoxy group or a cycloalkoxy group of the formula -OR 9 as defined above in R 4 and R 5 , wherein R 2 and R 3 are each a hydrogen atom, Halogen atom, (C 1 -C 4 ) alkyl group, (C 1 -C 4 ) alkoxy group and nitro group, where R 2 and R 3 are equally hydrogen atoms and when R 1 is a chloro atom, R is a phenyl group or 4-nitrophenyl group When R 1 is a hydroxyl group, R cannot be a phenyl group and R and R 1 are each -OR 6 or -OR 9 , wherein R 6 and R 9 are saturated hetero rings as defined above. And a hetero atom in this hetero ring cannot directly bond with an oxygen atom. 제1항에 있어서, R는 수소원자, 메르캅토기, (C1-C6)알킬기, 페닐기 치환페닐기 및 카르보-(C1-C4)알콕시기를 나타내고, 환화제를 트리알킬 오르토포름산염, 이황화탄소 및 하기 일반식의 산유도체에서 선택함을 특징으로 하는 상기 일반식(Ⅰ)의 화합물의 제조방법.The compound of claim 1, wherein R represents a hydrogen atom, a mercapto group, a (C 1 -C 6 ) alkyl group, a phenyl group substituted phenyl group and a carbo- (C 1 -C 4 ) alkoxy group, and the cyclizing agent is a trialkyl orthoformate salt. , Carbon disulfide and acid derivative of the following general formula. 상기 일반식에서 R은 (C1-C6)알킬기, 페닐기, 치환페닐기 또는 카르보-(C1-C4)알콕시기를 나타내며 X는 염소원자 또는 -OR″기를 나타낸다 여기서, R″는 메틸기, 에틸기,기, 트리플루오로아세틸기 또는 에톡카르보닐기임)In the general formula, R represents a (C 1 -C 6 ) alkyl group, a phenyl group, a substituted phenyl group or a carbo- (C 1 -C 4 ) alkoxy group, X represents a chlorine atom or an -OR ″ group, wherein R ″ represents a methyl group or an ethyl group , Group, trifluoroacetyl group or ethoxycarbonyl group) 제1항에 있어서, 대응하는 4-치환-1-히드라지노 프탈라진 유도체를 이황탄소로 환화시킨 다음 이렇게 생성된 R 및 R1이 메르캅토기인 상기 일반식(Ⅰ)의 트라이졸로 〔3,4-a〕프탈라진을 산화적 염소화 반응을시키고 이렇게 도입된 3-클로로(또는 6-클로로)치환체를 일반식의 아민, 알칼리금속 알콕시드 또는 시클로알콕시드 MeOR6로 임의적으로 치환 시킴을 특징으로 하는 R및 R1중의 적어도 한가지가 클로로 또는 일반식의 아미노 또는 치환아미노기 또는 일반식 -OR6의 알콕시기 또는 시클로알콕시기인 일반식(Ⅰ)의 화합물의 제조방법(상기식에서, R4, R5및 R6는 위에서 정의한 것과 같으며, Me는 알킬리금속의 양이온임).The trizolo of formula (I) according to claim 1, wherein the corresponding 4-substituted-1-hydrazino phthalazine derivative is cyclized to disulfide carbon, and then R and R 1 are mercapto groups. , 4-a] undergoes an oxidative chlorination reaction of phthalazine and the 3-chloro (or 6-chloro) substituent thus introduced Optionally substituted with an amine, an alkali metal alkoxide or cycloalkoxide MeOR 6 of at least one of R and R 1 is chloro or A process for the preparation of a compound of formula (I) wherein the amino or substituted amino group of or alkoxy group or cycloalkoxy group of formula -OR 6 (wherein R 4 , R 5 and R 6 are as defined above, Me is alkyl Cation of a ly metal. 제1항에 있어서, 대응하는 4-치환-1-히드라지노-프탈라진 유도체를 이황화탄소로써 환화시켜서 얻은 R가 메르캅토기인 일반식(Ⅰ)의 화합물을 (C1-C4)알킬 요오드화물과 반응시켜서 R가 (C1-C4)알킬티오기인 일반식(Ⅰ)의 대응화합물을 수득하고 만약 R가 (C1-C4)알킬술피닐기 또는 (C1-C4)알킬술포닐기인 일반식(Ⅰ)의 화합물이 요구된다면 위와 같이 얻은 화합물을 적당한 산화제를 사용하여 산화시킴을 특징으로 하는 R가 (C1-C4)알킬티오, (C1-C4)알킬술피닐 또는 (C1-C4)알킬술포닐인 일반식(Ⅰ)의 화합물을 제조하는 방법.The method of claim 1, wherein the substitution corresponding 4-1-hydrazino-R is a mercapto group, a compound of general formula (Ⅰ) obtained by cyclization of phthalazine derivatives as carbon disulfide (C 1 -C 4) alkyl R is reacted with iodide (C 1 -C 4) alkylthio group to give the corresponding compound of formula (ⅰ) and if R is (C 1 -C 4) alkoxy group or a (C 1 -C 4) alkyl If a compound of the general formula (I), which is a sulfonyl group, is required, the compound obtained as described above is oxidized using a suitable oxidizing agent, wherein R is (C 1 -C 4 ) alkylthio, (C 1 -C 4 ) alkylsulfonate. A process for preparing a compound of formula (I), which is pinyl or (C 1 -C 4 ) alkylsulfonyl. 하기 일반식(Ⅱ)의 4-치환-1-히드라지노-프탈라진을 일반식 R′-CHO의 알데히드( 이 식에서 R′는 (C1-C6)알킬기, 페닐기, 치환페닐기 또는 카르보(C1-C4)알콕시기를 나타냄)와 반응시켜서 생성된 하기 일반식(Ⅲ)의 히드라진을 산화제로써 처리하여 요구되는 최종 생성물로 환화시킴을 특징으로 하는 R가 (C1-C6)알킬기, 페닐기, 치환페닐기 또는 카르보(C1-C4)알콕시기인 전기 일반식(Ⅰ)의 화합물을 제조하는 방법.4-substituted-1-hydrazino-phthalazine of the following general formula (II) is substituted with an aldehyde of the general formula R′-CHO, wherein R ′ is a (C 1 -C 6 ) alkyl group, a phenyl group, a substituted phenyl group or a carbo R is a (C 1 -C 6 ) alkyl group, characterized in that the hydrazine of the following general formula (III) produced by the reaction with (C 1 -C 4 ) alkoxy group) is cyclized to the required final product. And a phenyl group, a substituted phenyl group or a carbo (C 1 -C 4 ) alkoxy group. 상기 일반식에서, R′,R1, R2및 R3는 제1항에 정의한 바와 같다.In the general formula, R ', R 1 , R 2 and R 3 are as defined in claim 1. R1이 할로겐원자인 전기 일반식(Ⅰ)의 대응화합물을 (C1-C4)알칸디올, 일반식의 아민 또는 치환아민 또는 일반식 MeOR9의 알칼리금속 알콕시 또는 시클로 알콕시드로 처리함을 특징으로 하는 R1이 (C1-C4)알킬티오, 일반식 |의 아미노 또는 치환아미노기 또는 일반식 -OR9의 알콕시기 또는 시클로 알콕시기인 일반식(Ⅰ)의 화합물의 제조방법(상기 일반식에서, R7,R8및 R9는 위에서 정의한 것과 같으며 Me는 알칼리 금속 양이온 임)The corresponding compound of the general formula (I) wherein R 1 is a halogen atom is selected from (C 1 -C 4 ) alkanediol R 1 is (C 1 -C 4 ) alkylthio, formulated by treatment with amines or substituted amines or alkali metal alkoxy or cyclo alkoxides of formula MeOR 9 | A process for preparing a compound of formula (I), wherein the amino or substituted amino group is an alkoxy group or a cycloalkoxy group of formula -OR 9 , wherein R 7 , R 8 and R 9 are as defined above Metal cation) 하기 일반식(Ⅶ)의 3-클로로-s-트리아졸로-프탈리진 또는 하기 일반식(Ⅷ)의 6-클로로-s-트리아졸로-프탈라진을 각각 대응하는 3-히드록시 또는 6-히드록시 유도체로 전환시켜서 얻은 중간체를 알칼리 금속 수소화물과 반응시킨 다음 각각 일반식 XR 또는 XR1의 화합물과반응시킴을 특징으로 하는 R가 OR6이고 R1이OR6인 일반식(Ⅰ)의 화합물의 제조방법.3-chloro-s-triazolo-phthalazine of the following general formula (VIII) or 6-chloro-s-triazolo-phthalazine of the following general formula (X) respectively corresponds to 3-hydroxy or 6- The intermediate obtained by conversion to a hydroxy derivative is reacted with an alkali metal hydride and then with a compound of formula XR or XR 1 , respectively, wherein R is OR 6 and R 1 is OR 6 . Method for preparing the compound. 하기 일반식(Ⅴ)의 3-히드록시-s-트리아졸로-프탈라진 또는 하기 일반식(Ⅵ)의 6-히드록시-s-트리아졸로-프탈라진을 알칼리 금속 수소화물과 반응시킨 다음 각각 일반식 X-R 또는 X-R1의 화합물과 반응시킴을 특징으로 하는 R1이 OR6이고 R1이 OR9인 전기 일반식(Ⅰ)의 화합물의 제조방법.Reacting 3-hydroxy-s-triazolo-phthalazine of the following general formula (V) or 6-hydroxy-s-triazolo-phthalazine of the following general formula (VI) with alkali metal hydride each formula XR or compound and reacting with a compound of general formula electricity (ⅰ) R 1 is oR 6 and R 1 is oR 9, characterized by a XR 1. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019830000174A 1982-01-18 1983-01-18 Process for the preparation of 6-substituted s-triagelo(3,4-a)phthalagine derivatives KR890000184B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8201273 1982-01-18
GB8201273 1982-01-18

Publications (2)

Publication Number Publication Date
KR840003254A true KR840003254A (en) 1984-08-20
KR890000184B1 KR890000184B1 (en) 1989-03-09

Family

ID=10527683

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830000174A KR890000184B1 (en) 1982-01-18 1983-01-18 Process for the preparation of 6-substituted s-triagelo(3,4-a)phthalagine derivatives

Country Status (20)

Country Link
US (1) US4788186A (en)
EP (1) EP0085840B1 (en)
JP (1) JPS58124786A (en)
KR (1) KR890000184B1 (en)
AT (1) ATE22562T1 (en)
AU (1) AU564026B2 (en)
CA (1) CA1214168A (en)
DE (1) DE3366494D1 (en)
DK (1) DK163145C (en)
ES (1) ES8601995A1 (en)
FI (1) FI81350C (en)
GR (1) GR78442B (en)
HU (1) HU193033B (en)
IE (1) IE55032B1 (en)
IL (1) IL67697A (en)
NO (1) NO161674C (en)
NZ (1) NZ203021A (en)
PH (1) PH21834A (en)
PT (1) PT76107A (en)
ZA (1) ZA83224B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194310B (en) * 1983-07-12 1988-09-14 Lepetit Spa TRIAZOLE DERIVATIVES (3,4-A) FTALAZINICI 3,6-DISOSTITUITI
CA2260900A1 (en) 1996-07-25 1998-02-05 Merck Sharp & Dohme Limited Substituted triazolo pyridazine derivatives as inverse agonists of the gabaa.alpha.5 receptor subtype
HUP0600527A2 (en) * 1996-07-25 2006-11-28 Merck Sharp & Dohme Substituted triazolo-pyridazine derivatives as ligands for gaba receptors, process for their preparation and pharmaceutical compositions containing them
CA2288789C (en) * 1997-05-08 2009-07-21 Merck Sharp & Dohme Limited Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as gaba alpha 5 ligands
ES2137113B1 (en) * 1997-07-29 2000-09-16 Almirall Prodesfarma Sa NEW DERIVATIVES OF TRIAZOLO-PIRIDAZINAS HETEROCICLICOS.
GB9715977D0 (en) * 1997-07-29 1997-10-01 Merck Sharp & Dohme Therapeutic agents
GB9726699D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
GB9723999D0 (en) 1997-11-13 1998-01-14 Merck Sharp & Dohme Therapeutic use
AU1041599A (en) * 1997-11-13 1999-06-07 Jose Luis Castro Pineiro Therapeutic uses of triazolo-pyridazine derivatives
GB9726701D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
GB9726702D0 (en) * 1997-12-18 1998-02-18 Merck Sharp & Dohme Therapeutic use
US6110915A (en) * 1997-12-18 2000-08-29 Merck & Co., Inc. Antiemetic use of triazolo-pyridazine derivatives
US6303597B1 (en) 1998-01-14 2001-10-16 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for GABA receptors
GB9801208D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801234D0 (en) * 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
YU43800A (en) 1998-01-21 2002-12-10 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for gaba receptors
GB9801210D0 (en) * 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801202D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801397D0 (en) 1998-01-22 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801538D0 (en) 1998-01-23 1998-03-25 Merck Sharp & Dohme Pharmaceutical product
NZ505695A (en) * 1998-02-25 2002-03-01 Merck Sharp & Dohme 3-(5-Methylisoxazol-3-yl)-6-(1-methyl-1,2,3-triazol-4-yl)methyloxy-1,2,4-triazolo[3,4-a]phthalazine and pharmaceuticals thereof and its use for the enhancement of cognition
US6448249B1 (en) 1998-02-25 2002-09-10 Merck Sharp & Dohme Ltd. Substituted 1,2,4-triazolo[3,4-A]phthalazine derivatives as GABAα5 ligands
GB9824897D0 (en) 1998-11-12 1999-01-06 Merck Sharp & Dohme Therapeutic compounds
CA2349700A1 (en) 1998-11-12 2000-05-18 Merck & Co., Inc. Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same
GB9929569D0 (en) * 1999-12-14 2000-02-09 Merck Sharp & Dohme Therapeutic agents
GB0028583D0 (en) 2000-11-23 2001-01-10 Merck Sharp & Dohme Therapeutic compounds
JP2004527531A (en) * 2001-04-10 2004-09-09 メルク エンド カムパニー インコーポレーテッド How to treat cancer
WO2002083140A1 (en) * 2001-04-10 2002-10-24 Merck & Co., Inc. Inhibitors of akt activity
US20060142178A1 (en) * 2002-04-08 2006-06-29 Barnett Stanley F Method of treating cancer
US20050054647A1 (en) * 2002-12-27 2005-03-10 Detlev Schuppan New pharmaceutical combination
JP5140427B2 (en) * 2004-09-02 2013-02-06 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング Triazolophthalazine
CA2591991C (en) * 2005-01-05 2013-11-19 Altana Pharma Ag Triazolophthalazines
AU2006204454B2 (en) 2005-01-05 2011-11-10 Takeda Gmbh Triazolophthalazines as PDE2-inhibitors
JP5913126B2 (en) 2009-12-31 2016-04-27 フンダシオン セントロ ナシオナル デ インベスティガシオネス オンコロヒカス カルロス ザ サードFundacion Centro Nacional de Investigaciones Oncologicas Carlos III Tricyclic compounds for use as kinase inhibitors
CN103694244B (en) * 2014-01-09 2016-03-30 郑州大学 3,6 replace-1,2,4-triazole also [3,4-a] Phthalazines and preparation thereof and purposes
CN104016986B (en) * 2014-03-13 2016-02-03 郑州大学 3-replaces-6-(1-substituted piperazinyl)-1,2,4-triazoles also [3,4-a] Phthalazines, Preparation Method And The Use
EP4279074A1 (en) * 2022-05-19 2023-11-22 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Azolo compounds for treatment of fibrotic diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2484029A (en) * 1945-12-21 1949-10-11 Ciba Pharm Prod Inc Hydrazine derivatives of pyridazine compounds
GB629177A (en) * 1945-12-21 1949-09-14 Ciba Ltd Manufacture of new hydrazine compounds and derivatives thereof
JPS5132598A (en) * 1974-09-13 1976-03-19 Eisai Co Ltd Toriazoro * 3 44 ee * futarajinjudotai no goseiho
JPS603080B2 (en) * 1976-08-10 1985-01-25 三菱化学株式会社 S-triazolo[3,4-α][5,6,7,8]tetrahydrophthalazines
GR70309B (en) * 1979-10-29 1982-09-08 Dow Chemical Co

Also Published As

Publication number Publication date
KR890000184B1 (en) 1989-03-09
NO161674B (en) 1989-06-05
NZ203021A (en) 1986-05-09
JPS58124786A (en) 1983-07-25
GR78442B (en) 1984-09-27
CA1214168A (en) 1986-11-18
DK163145C (en) 1992-06-22
IE830082L (en) 1983-07-18
NO830110L (en) 1983-07-19
ES531458A0 (en) 1985-11-01
AU564026B2 (en) 1987-07-30
DK163145B (en) 1992-01-27
ATE22562T1 (en) 1986-10-15
DK17983A (en) 1983-07-19
NO161674C (en) 1989-09-13
AU1055083A (en) 1983-07-28
EP0085840B1 (en) 1986-10-01
IE55032B1 (en) 1990-05-09
JPH048428B2 (en) 1992-02-17
US4788186A (en) 1988-11-29
ZA83224B (en) 1983-10-26
FI830100A0 (en) 1983-01-12
DE3366494D1 (en) 1986-11-06
IL67697A (en) 1990-02-09
DK17983D0 (en) 1983-01-18
ES8601995A1 (en) 1985-11-01
PT76107A (en) 1983-02-01
PH21834A (en) 1988-03-17
EP0085840A1 (en) 1983-08-17
IL67697A0 (en) 1983-05-15
FI81350C (en) 1990-10-10
FI81350B (en) 1990-06-29
HU193033B (en) 1987-08-28
FI830100L (en) 1983-07-19

Similar Documents

Publication Publication Date Title
KR840003254A (en) Method for preparing 6-substituted-s-triazolo [3,4-a] phthalazine derivatives
KR840006212A (en) Method for preparing 2-substituted phenyl-4, 5, 6, 7-tetrahydro-2H-indazoles
KR850001210A (en) Process for preparing pyrrolo- [1,2-a] imidazole and imidazo [1,2-a] pyridine derivative
NZ194302A (en) 8-(alkoxyphenyl) purines
ES2081211T3 (en) DYED OF KERATIN FIBERS WITH INDOLINS WITH METALLIC CATALYSIS.
KR830001274A (en) Method for producing imidazolyl vinyl ether
KR850005827A (en) Method for producing 2-substituted phenyl-3-chlorotetrahydro-2H-indazoles
KR860001808A (en) Method for preparing imidazo [1,5-a] pyrimidine derivative
ATE15896T1 (en) PYRIDAZINONE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS FUNGICIDES.
ES8301238A1 (en) Dioxo piperazine compounds
SE7613990L (en) ORATIC ACID DERIVATIVES TO PREPARE NEW 7-AMINO-T IAZOLYL-ACETAMIDO-CEPHALOSP
KR840006665A (en) Method for preparing 6-hydroxy lower alkyl penem compound
CA1221358A (en) 2-thiacephems and (5r) penems derivatives
KR840001974A (en) Preparation of 1- [3- (6-Fluoro-1,2-benzisoxazol-3-yl) propyl] -4- (substituted) -piperazine and -pyriridine
KR850007256A (en) Method for preparing tricyclic imidazole derivatives
IE42933B1 (en) Glyoxylic acid derivatives
ATE10629T1 (en) BENZOTRIAZOLE, THEIR PRODUCTION AND USE AS FUNGICIDES.
KR920008044A (en) Herbicide Compounds of Triazolopyridazines
ES8400111A1 (en) Pyrimidinecarbamate derivatives as intermediates
US4294970A (en) Oxidation of alpha-alkylated, benzyl-substituted 2-thiopyridine 1-oxides
Baudisch et al. NEW METHODS OF SPLITTING PYRIMIDINES. IV. A STUDY OF THE MECHANISM OF THE DECOMPOSITION OF THYMINE1
KR860002486A (en) Method for preparing thiazinephosphonic acid derivative
KR860000296A (en) Method for preparing isooxazoloquirollinone derivative
KR840006655A (en) Trans-dl-5-substituted-7-optionally substituted-4,4a, 5,6,7,8,8a, 9-octahydro-1H (and 2H) pyrazolo- [3,4-g]- Method for preparing quinazoline
KR890001403B1 (en) Process for preparing diamino pyrimidine derivatives

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19920207

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee